PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of arthrestherBioMed Centralbiomed central web sitesearchsubmit a manuscriptregisterthis articleArthritis Research & Therapy
 
Arthritis Res Ther. 2003; 5(2): 54–67.
Published online Jan 14, 2003.
PMCID: PMC165033
Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action
Larry W Morelandcorresponding author1
1University of Alabama at Birmingham, Birmingham, AL, USA
corresponding authorCorresponding author.
Larry W Moreland: Larry.Moreland/at/ccc.uab.edu
Received October 4, 2002; Revised November 7, 2002; Accepted December 12, 2002.
Abstract
Although the predominant mechanism of intra-articular hyaluronan (hyaluronic acid) (HA) and hylans for the treatment of pain associated with knee osteoarthritis (OA) is unknown, in vivo, in vitro, and clinical studies demonstrate various physiological effects of exogenous HA. HA can reduce nerve impulses and nerve sensitivity associated with the pain of OA. In experimental OA, this glycosaminoglycan has protective effects on cartilage, which may be mediated by its molecular and cellular effects observed in vitro. Exogenous HA enhances chondrocyte HA and proteoglycan synthesis, reduces the production and activity of proinflammatory mediators and matrix metalloproteinases, and alters the behavior of immune cells. Many of the physiological effects of exogenous HA may be a function of its molecular weight. Several physiological effects probably contribute to the mechanisms by which HA and hylans exert their clinical effects in knee OA.
Keywords: cartilage, hyaluronan, hylan, mechanism of action, osteoarthritis
Articles from Arthritis Research & Therapy are provided here courtesy of
BioMed Central